Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...
Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas. The ...
At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...
Eli Lilly announces plans to build four new U.S. manufacturing facilities, enhancing domestic pharmaceutical production and creating jobs.
Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...
The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.
Pharmaceutical giants like Eli Lilly and Grifols report significant investment and growth. In the U.S., Eli Lilly plans a $27 billion investment in manufacturing plants, while Grifols reports a 10% ...
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
Eli Lilly plans to invest at least $27 billion to build four new manufacturing sites in the U.S., a week after President Trump reportedly said he planned to impose tariffs of 25% or more on ...
A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results